ClinicalTrials HQ

Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy

Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy

Active, not recruiting · NCT03603795 · Registry updated 2024-10-29
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study Impact on Outcome of Eltrombopag in Elderly Patients with Acute Myeloid Leukemia Receiving Induction ChemotherapyHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmActive, not recruitingPhase 22024-10-29NCT03603795

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
French Innovative Leukemia Organisation17
Novartis Pharmaceuticals432

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
CH de la Côte Basque - HématologieBayonneFrance2
CHU ANGERS - Maladies du sangAngersFrance2
Chu CaremeauNîmesFrance3
CHU de BraboisVandœuvre-lès-NancyFrance1
Chu EstaingClermont-FerrandFrance14
CHU Grenoble - Hématologie CliniqueGrenobleFrance2
CHU Hautepierre - HématologieStrasbourgFrance2
CHU HOTEL DIEU - Hématologie CliniqueNantesFrance2
CHU La Milétrie - Hématologie CliniquePoitiersFrance2
CHU PontchaillouRennesFrance8
HOPITAL E. MULLER - HématologieMulhouseFrance2
Hôpital Saint-Eloi - Hématologie CliniqueMontpellierFrance4
Institut Paoli-Calmettes - Hématologie 2MarseilleFrance2
Institut Universitaire du Cancer de Toulouse Oncopole - Service d'HématologieToulouseFrance2
Sponsor FILOToursFrance1